Max-Planck-Institut Für Biochemie Max Planck Institute of Biochemistry

Total Page:16

File Type:pdf, Size:1020Kb

Max-Planck-Institut Für Biochemie Max Planck Institute of Biochemistry max-planck-institut für biochemie max planck institute of biochemistry MF | 1 Kontakt Contact Max-Planck-Institut für Biochemie Am Klopferspitz 18 D - 82152 Martinsried Tel.: + 49 (89) 8578 - 0 Fax: + 49 (89) 8578 - 3777 Öffentlichkeitsarbeit Anja Konschak Tel.: + 49 (89) 8578 - 2824 Fax: + 49 (89) 8578 - 2943 E-Mail: [email protected] Inhalt Contents Forschungsziele Aims of Research 4-5 Daten und Fakten Facts and Figures 6-7 Die Max-Planck-Gesellschaft The Max Planck Society 8-9 Strukturforschung Structural Research 10-11 Molekulare Strukturbiologie Molecular Structural Biology 12-13 Molekulare Mechanismen der DNA-Reparatur Molecular Mechanisms of DNA Repair 14-15 Zelluläre Strukturbiologie Structural Cell Biology 16-17 Modellierung von Proteinkomplexen Modeling of Protein Complexes 18-19 Zelluläre Biochemie Cellular Biochemistry 20-21 Chaperonin-vermittelte Proteinfaltung Chaperonin-Assisted Protein Folding 22-23 Strukturbiologie der Zilien Structural Biology of Cilia 24-25 Zellbiologie, Signal übertragung Cell Biology, Signal und Regulation Transduction and Regulation 26-27 Molekulare Grundlagen des Proteintransports Molecular Basis of Protein Trafficking 28-29 Molekulare Medizin Molecular Medicine 30-31 Molekulare Mechanotransduktion Molecular Mechanotransduction 32-33 Chromosomale Organisation und Dynamik Chromosome Organization and Dynamics 34-35 Molekulare Zellbiologie Molecular Cell Biology 36-37 Proteinanalytik Protein Analysis 38-39 Proteomics und Signaltransduktion Proteomics and Signal Transduction 40-41 Chromatin-Biologie Chromatin Biology 42-43 Translationale Medizin Translational Medicine 44-45 DNA-Replikation und Genom-Integrität DNA Replication and Genome Integrity 46-47 Angeborene Immunität Innate Immunity 48-49 Molekulare Immunologie und Signaltransduktion Molecular Immunology and Signal Transduction 50-51 Muskeldynamik Muscle Dynamics 52-53 Zelluläre und molekulare Biophysik Cellular and Molecular Biophysics 54-55 Genomische Stabilität Maintenance of Genome Stability 56-57 Molekularbiologie Molecular Biology 58-59 Zelluläre Dynamik und Musterbildung Cellular Dynamics and Cell Patterning 60-61 Molekulare Membran- und Organell-Biologie Molecular Membrane and Organelle Biology 62-63 Biologie der Chromosomen Chromosome Biology 64-65 Emeriti Emeritus Directors 66-67 Max Planck Fellows und Externe Max Planck Fellows and 68-69 Wissenschaftliche Mitglieder External Scientific Members 2 | 3 Vernetzte Forschung Networked Research 70-71 Das Forschen und Leben leichter machen Making Research and Life Easier 72-75 Den Nachwuchs fördern Supporting the Young Generation 76-77 Organisation Organization 78 Impressum Imprint 79 Stand: Frühjahr 2012 Max-Planck-Institut für Biochemie Max Planck Institute of Biochemistry Forschungsziele Spurensuche im molekularen Räderwerk der Zelle Aims of Research Searching for Clues to the Molecular Mechanisms of the Cell ebende Zellen sind hochkomplexe Gebilde, in iving cells are highly complex entities in which Ldenen eine Vielzahl von Molekülen zusammen La multitude of molecules work together to arbeitet, damit unser Organismus funktioniert. make our organism function. Without proteins Ohne Eiweiße (Proteine) wäre dies undenkbar: this would be inconceivable: They coordinate Sie koordinieren das Räderwerk der Zelle, indem the mechanisms of the cell by implementing the Proteine Eiweiße (Proteine) sind sie die in den Genen enthaltenen Informationen information contained in the genes into cellular große Moleküle, die aus in zelluläre Abläufe und Strukturen übersetzen. processes and structures. Proteins give cells their zu Ketten verbundenen Proteine verleihen den Zellen ihre Gestalt und shape and are the main protagonists in all cellular Aminosäuren aufgebaut sind die Hauptakteure in allen Zellprozessen: sei processes – whether they transport substances, sind. Diese Ketten können es, indem sie Stoffe transportieren, Botschaf- convey messages or carry out vital processes in bis zu mehrere tausend Aminosäuren lang sein. ten übermitteln oder als molekulare Maschinen their role as molecular machines. Der Standardsatz, aus dem lebenswichtige Prozesse durchführen. What decides which genes are translated alle Proteine zusammenge- Was aber entscheidet, welche Gene in Pro- into proteins? How do proteins regulate highly setzt werden, besteht aus teine übersetzt werden? Wie steuern Pro- complex cell processes and how do cells 21 verschiedenen Amino- teine hochkomplexe Zellprozesse und wie communicate with each other? Which control säuren. Jedes Protein besitzt eine ganz bestimmte kommunizieren Zellen miteinander? Welche mechanisms are effective in these processes and dreidimensionale Struktur, Kontroll mechanismen werden dabei wirksam und what happens when errors are made? die entscheidend ist, damit was geschieht bei Fehlern? All these are questions that the scientists of es korrekt funktioniert. All dies sind Fragen, denen die Wissenschaft- the Max Planck Institute of Biochemistry (MPIB) ler des Max-Planck-Instituts für Biochemie (MPIB) are seeking to answer. To elucidate the rules of Proteom Die Gesamtheit aller Pro- nachgehen. Um zu verstehen, nach welchen Re- cell division and specialization and to understand teine in einem Lebewesen, geln Zellen sich teilen, sich spezialisieren und how cells fulfill their tasks in the body, the einem Gewebe, einer Zelle ihre Aufgaben im Körper erfüllen, untersuchen scientists are investigating the structure and oder einem Zellbestand- sie die Struktur und die Funktion der beteiligten function of the molecules involved. The size of the teil zu einem bestimmten Mole küle. Die Größenskala der „Untersuchungs- “study subjects” ranges in scale from the Zeitpunkt. objekte“ reicht dabei von einzelnen Molekülen individual molecule and the cell up to the entire über die Zelle bis hin zu ganzen Geweben und tissue and the organism. With this research focus, Organismen. Mit diesen Forschungsschwer- the Institute is an international leader in protein punkten ist das Institut in der Proteinforschung research. Increasingly, the Institute’s classic international führend, wobei seine klassischen research areas of structural, cell and molecular Forschungsbereiche Struktur-, Zell- und Moleku- biology and biochemistry are developing in the larbiologie sowie Biochemie sich zunehmend in direction of structural biochemistry, systems Richtung strukturelle Biochemie, Systembiologie, biology, biophysics, genetics and new imaging Biophysik, Genetik und neue Bildgebungsmetho- methods. Moreover, bioinformatics is playing an den entwickeln; auch die Bioinformatik spielt eine ever more significant role. große Rolle. Biomedical basic research is likewise an Die biomedizinische Grundlagenforschung ist important aspect, because disturbances of Proteins ebenfalls ein wichtiger Aspekt, denn Störungen cellular signal transduction or abnormal protein Proteins are large der zellulären Signalübertragung oder fehler- structures lead to diseases such as cancer, molecules which are hafte Proteinstrukturen führen zu Krankheiten diabetes or Alzheimer’s. Deeper insight into the made of amino acids linked together in wie Krebs, Diabetes oder Alzheimer. Der tiefere cellular mechanisms and structures also helps chains. These chains Einblick in zelluläre Mechanismen und Strukturen to better understand the pathogenesis of these can be up to several hilft auch, die Entstehung dieser Krankheiten bes- diseases and to develop new strategies for thousand amino acids ser zu verstehen und neue Therapiestrategien zu therapy. long. The standard set entwickeln. For their analyses, the researchers use of all proteins consists of 21 different amino Für ihre Analysen verwenden die Forscher ein a broad spectrum of ultra-modern methods acids. Each protein breites Spektrum hochmoderner Methoden, die partly developed directly at the MPIB. The has a specific three- teilweise direkt am MPIB entwickelt wurden. Die methodological expertise, which has increased dimensional structure über Jahre gewachsene methodische Expertise, over the years and covers all of the research which is essential for it die sämtliche Forschungsbereiche des Instituts areas of the Institute, is a special strength of the to function correctly. abdeckt, ist eine besondere Stärke des MPIB. MPIB. In particular, new methods in electron and Proteome Sie macht die Umsetzung der Forschungsvorha- light microscopy and mass spectrometry offer The total of all proteins ben überhaupt erst möglich. Insbesondere neue previously unimagined opportunities for gaining in an organism, a Methoden in der Elektronen- und Lichtmikros- insights into cells. tissue, a cell or a kopie sowie der Massenspektrometrie bieten cell component at a particular point in time. einzigartige Möglichkeiten, Einblicke in Zellen zu gewinnen. 4 | 5 Max-Planck-Institut für Biochemie Max Planck Institute of Biochemistry Daten und Fakten Facts and Figures as Max-Planck-Institut für Biochemie (MPIB) he Max Planck Institute of Biochemistry Dist ein internationales Forschungsinstitut, T(MPIB) is an international research institute dessen Wissenschaftlerinnen und Wissenschaft- whose scientists are primarily concerned with ler sich vor allem mit der Erforschung der Struk- research on the structure and function of proteins. tur und Funktion von Proteinen beschäftigen. Die The excellence of research at the MPIB is hohe Qualität der Wissenschaft am MPIB wird reflected in the quality and number of publications sowohl durch die exzellente Publikationsleistung in international, peer-reviewed journals and
Recommended publications
  • Stefan Jentsch (1955-2016) Obituary
    Repository of the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association http://edoc.mdc-berlin.de/16412 Stefan Jentsch (1955-2016) Obituary Sommer, T. and Hoppe, T. and Rape, M. NOTICE: this is the author’s version of a work that was accepted for publication in Cell. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in: Molecular Cell 2016 DEC 15 ; 64(6): 1011-1012 2016 DEC 15 (first published online) doi: 10.1016/j.molcel.2016.12.001 Publisher: Cell Press / Elsevier © 2016 Elsevier. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ or send a letter to Creative Commons, PO Box 1866, Mountain View, CA 94042, USA. Stefan Jentsch (1955-2016) Stefan Jentsch, whose unusual creativity and trailblazing work changed forever the fields of ubiquitin biology, DNA repair, splicing, and autophagy, sadly passed away in Munich on October 29 after a short and severe illness. Stefan was born in Berlin on May 29th 1955. Following his school and university years, Stefan also embarked on his graduate thesis in his still divided hometown and joined Thomas Trautner’s group at the Max Planck Institute of Molecular Genetics. His dissertation work on DNA modifications by methyltransferases, completed in 1983, already focused on one of his life-long scientific passions, the intricate crosstalk between DNA and proteins.
    [Show full text]
  • Abstract Book Table of Contents
    Abstract Book TABLE OF CONTENTS Programme of the Symposium 1 Speakers Frederick W. Alt 2 Bradley Cairns 4 Ingrid Grummt 6 John Gurdon 8 Rudolf Jaenisch 10 Stefan Jentsch 12 Josef Jiricny 14 Renato Paro 16 Alexander Schier 18 Natalia Soshnikova 20 Vijay Tiwari 22 Ernst-Ludwig Winnacker 24 Notes 26 Upcoming Events at IMB 36 Imprint 40 PROGRAMME OF THE SYMPOSIUM Welcome Address 09:00 Christof Niehrs IMB, Mainz, Germany Lectures 09:20 Ernst-Ludwig Winnacker Secretary General, Human Frontier Science Program, Strasbourg, France 10:00 Bradley Cairns HHMI Huntsman Cancer Institute, Salt Lake City, USA 10:40 Vijay Tiwari IMB, Mainz, Germany 11:00 Coffee Break 11:20 Alexander Schier Harvard University, Cambridge, USA 12:00 Josef Jiricny Institute of Molecular Cancer Research, Zurich, Switzerland 12:40 Natalia Soshnikova IMB, Mainz, Germany 13:00 Lunch Break 14:30 Stefan Jentsch Max Planck Institute, Martinsried, Germany 15:10 Renato Paro D-BSSE, ETH Zurich, Basel, Switzerland 15:50 Ingrid Grummt DKFZ, Heidelberg, Germany 16:30 Coffee Break 16:50 John Gurdon The Gurdon Institute, Cambridge, UK 17:30 Rudolf Jaenisch Whitehead Institute, MIT, Cambridge, USA Keynote Lecture 18:10 Frederick W. Alt HHMI & Harvard University Children‘s Hospital Boston, USA 19:00 Closing Remarks 1 Dr Alt received his Ph.D. from Stanford in 1977 with Robert Schimke, where he discovered gene amplification, providing the first evidence for genetic instability in mammalian cells. He did postdoctoral work at MIT with David Baltimore, where he worked out basic principles of immune system recombination and lymphocyte development. He has continued to be a leader in these two general research areas throughout his career.
    [Show full text]
  • Newsletter of the German Society for Cell Biology Full Electronic Version Volume 47, 1 2021
    Cell News Newsletter of the German Society for Cell Biology full electronic version Volume 47, 1 2021 DGZ Prize Winners 2020 Imaging the near-to-native state ZEISS Correlative Cryo Workflow Connect widefield, laser scanning, and FIB-SEM microscopes in a seamless and easy-to-use procedure. ZEISS Correlative Cryo Workflow provides hardware and software optimized for the needs of correlative cryogenic microscopy, from localization of fluorescent macromolecules to high-contrast volume imaging and on-grid lamella thinning for cryo electron tomography. zeiss.com/cryo CONTENT Editorial 4 Executive Board DGZ International Meeting, September 27-29, 2021 5 President: Roland Wedlich-Söldner DGZ Prize Winners 2020 (Universität Münster) Carl Zeiss Lecture Vice President: Petra Schwille: How relevant is physiological relevance? Gislene Pereira A physicist’s journey in and out of cell biology 6 (Universität Heidelberg) Chief Executive Officer (CEO): Nikon Young Scientist Award Sandra Iden Chun So: Liquid-liquid phase separation organizes microtubule regulatory proteins for acentrosomal spindle assembly in mammalian oocytes 11 (Universität des Saarlandes) Vice CEO: BINDER Innovation Prize Ralf Jungmann Christian Münch: Proteomics of dynamic cell changes upon stress 18 (LMU und Max Planck Institut für Werner Risau Prize Biochemie) Katerina Rohlenova: Endothelial metabolic transcriptome plasticity in pathological angiogenesis 23 Advisory Board DGZ Awards 2021 M. Cristina Cardoso Thomas Dresselhaus Walther Flemming Award 2021 32 Jan Ellenberg Volker Gerke
    [Show full text]
  • A N N E X E S
    A n n e x e s Heidelberg: Realising the Potential of a Crompehensive University – Annexes Contents: PARTNERS OF THE UNIVERSITY ..........................................................................73 List of Signatures .............................................................................................................................. 73 Figure A1: Cooperation of the Heidelberg University with universities and research institutions in the USA........................................................................................................................ 75 Letters of Intent ................................................................................................................................. 76 ANNEX 1 – BASIC UNIVERSITY DATA...................................................................86 Table A1: Total budget, fraction thereof third-party funding [non-weighted 2006] ...................... 87 Table A2: Total resources distributed as a function of performance, and their distribution ........ 87 Table A3: Third-party funding ...................................................................................................... 87 Table A4: Student capacity.......................................................................................................... 88 Table A5: Enrolled students......................................................................................................... 89 Table A6: Number of Professors ................................................................................................
    [Show full text]
  • Research Report 2015 / 2016 Scientific Advisory Board
    RESEARCH REPORT 2015 / 2016 SCIENTIFIC ADVISORY BOARD Prof. Dr. Karl-Heinz Altmann Prof. Dr. Stefan Offermanns Institut für Pharmazeutische Max-Planck-Institut für Herz- und Wissenschaften, ETH Zürich Lungenforschung, Bad Nauheim (seit 01 / 2012) (seit 01 / 2016) Prof. Dr. Nils Brose Prof. Dr. Petra Schwille (Vorsitzender) Max-Planck-Institut für Biochemie, Max-Planck-Institut für Experimentelle Martinsried Medizin, Göttingen (seit 01 / 2012) (seit 01 / 2012) Prof. Dr. Rebecca Wade Prof. Dr. Ulrike Eggert (Stellvertretende Vorsitzende) Randall Division of Cell and Molecular Heidelberg Institute for Theoretical Biophysics, King´s College London Studies, HITS gGmbH (seit 01 / 2013) (seit 01 / 2013) Dr. Matthias Gottwald Bayer Pharma AG, Berlin (seit 01 / 2016) Prof. Dr. Thomas Gudermann Walter-Straub-Institut für Pharmakologie und Toxikologie, Ludwig-Maximilians-Universität München (seit 01 / 2013) Prof. Dr. Eckart Gundelfinger Leibniz-Institut für Neurobiologie, Magdeburg (seit 01 / 2013) Prof. Dr. Gerhard Klebe Institut für Pharmazeutische Chemie, Universität Marburg (seit 01 / 2009) Prof. Dr. Beat Meier Laboratorium für Physikalische Chemie, ETH Zürich (seit 01 / 2013) Stichtag 31.12.2016 RESEARCH REPORT 2015 / 2016 2 RESEARCH REPORT FORSCHUNGSBERICHT 2015 / 2016 CONTENTS INHALT PREFACE Interview with Director Dorothea Fiedler VORWORT What's new at the FMP? Was ist neu am FMP? 4 RESEARCH HIGHLIGHTS The cause of muscle weakness reveals the organisational principle in cells AKTUELLES AUS Ursache von vererbter Muskelschwäche aufgeklärt 8 DER FORSCHUNG Milestone for Parkinson's research: The amyloid protein α-synuclein is visualised in the cell for the first time Meilenstein für die Parkinson-Forschung: Amyloid-Protein α-synuclein erstmals in Zelle sichtbar gemacht 9 Double mechanism confirmed: How inositol pyrophosphates alter proteins Doppelter Mechanismus bestätigt: Wie Inositol-Pyrophosphate Proteine verändern 10 Interview with Thomas J.
    [Show full text]
  • Epigenesys: Epigenetics Meets Systems Biology
    SUMMER 2012 ISSUE 21 encounters The camera instead THE of test tubes EMBO PAGE 5 JOURNAL PAGE 2 The EMBO Journal is 30 PAGE 7 A network of excellence EpiGeneSys: Epigenetics meets systems biology 4DCellFate A project funded by the European LECTURE Denis Noble, President of the Meeting of minds Are scientists and artists Commission Seventh Framework Programme International Union of Physiological driven by a similar kind of deeply rooted wants to investigate how protein complexes Sciences and Professor Emeritus of curiosity? Visual artists and researchers regulate differentiation in embryonic stem cells. Oxford University, was in Heidelberg on involved in the MitoSys project want to fi nd out. 28 February to give a lecture on systems biology at the Print Media Academy. PAGE 7 PAGE 9 PAGE 13 www.embo.org THE EMBO JOURNAL IS 30 The EMBO Journal is 30 A 30th anniversary invites refl ection on change and progress. Here senior editors past and present look back on the early days of THE EMBO JOURNAL.1 John Tooze. “The EMBO Council of the day felt for worry about that a journal would help cement the EMBO manuscript fl ow membership, and, if successful, it would market changed from too few the name of EMBO to a worldwide audience and to too many, while the possibly generate income. quality issue remained. But would we get enough high-quality manu- I remember during a John Tooze scripts to produce a journal that would add lustre family holiday standing to EMBO’s name or would we drift into medioc- in a telephone box in a Rockefeller University rity and fi nancial inconsequentiality? rain storm on the Isle of Founding Editor In the earliest years, I was often very anxious Skye suggesting referees based on titles and 1982 –2003 about manuscript numbers and quality.
    [Show full text]
  • Stefan Jentsch (1955-2016) Obituary
    Repository of the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association http://edoc.mdc-berlin.de/16361 Stefan Jentsch (1955-2016) Obituary Sommer, T. and Hoppe, T. and Rape, M. NOTICE: this is the author’s version of a work that was accepted for publication in Cell. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in: Cell 2016 DEC 15 ; 167(7): 1667-1668 2016 DEC 15 (first published online) doi: 10.1016/j.cell.2016.11.057 Publisher: Cell Press / Elsevier © 2016 Elsevier. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ or send a letter to Creative Commons, PO Box 1866, Mountain View, CA 94042, USA. Stefan Jentsch (1955-2016) Stefan Jentsch, whose unusual creativity and trailblazing work changed forever the fields of ubiquitin biology, DNA repair, splicing, and autophagy, sadly passed away in Munich on October 29 after a short and severe illness. Stefan was born in Berlin on May 29th 1955. Following his school and university years, Stefan also embarked on his graduate thesis in his still divided hometown and joined Thomas Trautner’s group at the Max Planck Institute of Molecular Genetics. His dissertation work on DNA modifications by methyltransferases, completed in 1983, already focused on one of his life-long scientific passions, the intricate crosstalk between DNA and proteins.
    [Show full text]
  • Annual Report Fy 2017 Human Frontier Science Program
    APRIL 2017 APRIL 2017 — MARCH 2018 ANNUAL REPORT FY 2017 HUMAN FRONTIER SCIENCE PROGRAM The Human Frontier Science Program is unique, supporting international collaboration to undertake innovative, risky, basic research at the frontier of the life sciences. Special emphasis is given to the support and training of independent young investigators, beginning at the postdoctoral level. The Program is implemented by an international organisation, supported financially by Australia, Canada, France, Germany, India, Italy, Japan, the Republic of Korea, New Zealand, Norway, Singapore, Switzerland, the United Kingdom, the United States of America, and the European Commission. Since 1990, over 7000 researchers from more than 70 countries have been supported. Of these, 27 HFSP awardees have gone on to receive the Nobel Prize. 2 The following documents are available on the HFSP website www.hfsp.org: Joint Communiqués (Tokyo 1992, Washington 1997, Berlin 2002, Bern 2004, Ottawa 2007, Canberra 2010, Brussels 2013, London 2016): http://www.hfsp.org/about-us/governance/intergovernmental-conference Statutes of the International Human Frontier Science Program Organization: http://www.hfsp.org/about-us/governance/statutes Guidelines for the participation of new members in HFSPO: http://www.hfsp.org/about-us/new-membership General reviews of the HFSP (1996, 2001, 2006-2007, 2010): http://www.hfsp.org/about-us/reviews-hfsp Updated and previous lists of awards, including titles and abstracts: http://www.hfsp.org/awardees 3 TABLE OF CONTENTS INTRODUCTION Table of contents 4 President’s Message Introducing HFSPO 8 Introducing HFSPO 11 Report of the Secretary General 13 CHAPTER 1 - FELLOWSHIP PROGRAM 1.1 Introduction 18 1.2 Selection of HFSP Fellowships awarded in March 2018 20 1.3 The 2018 Fellowship Review Committee 23 1.4 Awardees lists: 25 1.
    [Show full text]
  • Newsletter of the German Society for Cell Biology Full Electronic Version Volume 42, 3&4 2016
    Cell News Newsletter of the German Society for Cell Biology full electronic version Volume 42, 3&4 2016 DGZ Spring Member Meeting 2017 in Leipzig DGZ Awards 2017 Adding efficiency to your fluorescence imaging. ZEISS Celldiscoverer 7 New Product! Your Flexible Automated Microscope // INNOVATION MADE BY ZEISS Your automated platform for live cell imaging Imagine the ease of use and automation of a boxed microscope – combined with the image quality and flexibility of a classical research microscope. Imagine this system calibrates itself, detects and focusses your samples and adaptive optics adjust themselves automatically. ZEISS Celldiscoverer 7 is your reliable automated research platform. No matter if you work with 2D or 3D cell culture, tissue sections or small model organisms. With Celldiscoverer 7 you increase the efficiency of your research. You acquire better data in a shorter time. www.zeiss.com/celldiscoverer CONTENT Newsletter of the German Society for Cell Biology Preface 4 Executive Board DGZ Spring Member Meeting 2017 in Leipzig President: Tentative Scientific Program 5 Carien Niessen (Cologne) General Information 6 Vice President: Carl Zeiss Lecture: Peter Walter 7 Oliver Gruss (Bonn) Simone Reber, Session 1: 8 Cell biology by numbers Chief Executive Officer (CEO): Martin Beck, Session 2: 9 Thomas M. Magin (Leipzig) Mechanisms of nucleocytoplasmic exchange Susanne Önel, Session 3: 10 Vice CEO: New insights into cell-cell fusion: Mechanisms of membrane fusion Karin Schumacher (Heidelberg) Julia Gross, Session 4: 11 Advisory Board
    [Show full text]